|
|
Post by mounts on Aug 13, 2023 16:16:21 GMT -5
|
|
|
|
Post by mayday on Aug 13, 2023 16:30:53 GMT -5
Thanks for the info.
|
|
|
|
Post by neil36 on Aug 13, 2023 18:48:06 GMT -5
I expect MNKD to start registering on more and more stock screeners. The revenue growth numbers are there. Profitability and debt metrics will steadily improve over time
Thanks for sharing this
|
|
|
|
Post by BD on Aug 13, 2023 20:14:04 GMT -5
Thanks. I notice that 2/3 of the strength is in the "timing" category, which to me implies some trading guesswork on the part of this screener. When it gets to 2/3 "positive strength" that will be a lot more convincing. Just my .0002.
|
|
|
|
Post by phdedieu12 on Aug 14, 2023 9:07:31 GMT -5
Not sure how they figure industry strength, considering MNKD did very well against its peers. Are they looking at overall pharmaceutical industry or comparable small biotech companies
|
|
|
|
Post by mytakeonit on Aug 14, 2023 12:52:31 GMT -5
Looks like Chaikin doesn't have much pull ... up one penny.
|
|
|
|
Post by boytroy88 on Aug 16, 2023 15:22:57 GMT -5
Looks like Chaikin doesn't have much pull ... up one penny. Down to $5.05... |
|
|
|
Post by cretin11 on Aug 16, 2023 15:54:43 GMT -5
Chaikin must be one of those shorts in long's clothing i.e. fake longs that we hear about. Shame on Chaikin for his nefarious manipulation of our share price. Possibly naked shorting too! Not to be confused with Naked Gun or Naked Lunch...
|
|
|
|
Post by prcgorman2 on Aug 17, 2023 16:28:36 GMT -5
Thank you mounts for sharing the ratings. They are interesting and also gratifying. I wonder if you could help with a couple of questions. The "Proj 1 year P/E" in both categories had a value of 77.45. I would ordinarily think that was a good P/E ratio (77.45:1), but given that's a relatively high P/E number, I was curious if you might be able to learn and share how that was calculated? Also, since the ratings show a P/E of 77.45, can you discover why the "Projected P/E" temperature reading is nevertheless in the red? I can speculate why P/E looked good but was still in the red, but thought it would be better to ask. Thanks in advance for anything you may be able to share. |
|
|
|
Post by peppy on Aug 17, 2023 17:45:24 GMT -5
What Is the Chaikin Oscillator? The Chaikin oscillator is named for its creator Marc Chaikin. The oscillator measures the accumulation-distribution line of moving average convergence-divergence (MACD). To calculate the Chaikin oscillator, subtract a 10-day exponential moving average (EMA) of the accumulation-distribution line from a 3-day EMA of the accumulation-distribution line. This measures momentum predicted by oscillations around the accumulation-distribution line. ====================================================================================== I put a Chalkin oscillator on a monthly chart..... schrts.co/AfybcjvQThe first post on this thread, they made the oscillator look special. It is an oscillator. |
|
|
|
Post by runner on Aug 17, 2023 19:29:43 GMT -5
PRC and Peppy: Thanks for delving deeper into this Chaikin thing. I hadn’t heard of it until yesterday.
Pep: As you point out, it’s an oscillator.
|
|
|
|
Post by awesomo on Aug 17, 2023 23:17:46 GMT -5
Thank you mounts for sharing the ratings. They are interesting and also gratifying. I wonder if you could help with a couple of questions. The "Proj 1 year P/E" in both categories had a value of 77.45. I would ordinarily think that was a good P/E ratio (77.45:1), but given that's a relatively high P/E number, I was curious if you might be able to learn and share how that was calculated? Also, since the ratings show a P/E of 77.45, can you discover why the "Projected P/E" temperature reading is nevertheless in the red? I can speculate why P/E looked good but was still in the red, but thought it would be better to ask. Thanks in advance for anything you may be able to share. A P/E ratio of 77.5:1 is extremely high, that's why it is in the red. Average biotech P/E is 17.17. Not sure where you are getting that this dashboard is showing that the "P/E looked good". |
|
|
|
Post by prcgorman2 on Aug 18, 2023 7:50:55 GMT -5
Thank you mounts for sharing the ratings. They are interesting and also gratifying. I wonder if you could help with a couple of questions. The "Proj 1 year P/E" in both categories had a value of 77.45. I would ordinarily think that was a good P/E ratio (77.45:1), but given that's a relatively high P/E number, I was curious if you might be able to learn and share how that was calculated? Also, since the ratings show a P/E of 77.45, can you discover why the "Projected P/E" temperature reading is nevertheless in the red? I can speculate why P/E looked good but was still in the red, but thought it would be better to ask. Thanks in advance for anything you may be able to share. A P/E ratio of 77.5:1 is extremely high, that's why it is in the red. Average biotech P/E is 17.17. Not sure where you are getting that this dashboard is showing that the "P/E looked good". Seriously? A share price to earnings ratio of 77.5:1 is very high, very rare, and under normal circumstances extremely good. A very high P/E ratio indicates buyers of shares are literally willing to pay $77.50 for every $1 in earnings per share. Because MannKind has yet to report a profit either using Generally Accepted Accounting Principles (GAAP) or even using pro forma non-GAAP accounting principles, I don’t know how the Chaikin Analytics Power Gauge (a proprietary technical investing tool) calculated the P/E, which is why I asked. I think of you as being a savvy yet grumpy investor (or very much like one) and so I’m surprised you would question whether a high P/E ratio is good or not. A very high P/E is unquestionably good for buy-and-hold “long” investors (but could be Hell on shorts), but in this case, hard to fathom because it’s obviously not based on conventional methods of determining P/E. |
|
|
|
Post by cretin11 on Aug 18, 2023 8:41:22 GMT -5
LOL that’s one way to look at it! 🤪
|
|
|
|
Post by awesomo on Aug 18, 2023 9:43:21 GMT -5
A P/E ratio of 77.5:1 is extremely high, that's why it is in the red. Average biotech P/E is 17.17. Not sure where you are getting that this dashboard is showing that the "P/E looked good". Seriously? A share price to earnings ratio of 77.5:1 is very high, very rare, and under normal circumstances extremely good. A very high P/E ratio indicates buyers of shares are literally willing to pay $77.50 for every $1 in earnings per share. Because MannKind has yet to report a profit either using Generally Accepted Accounting Principles (GAAP) or even using pro forma non-GAAP accounting principles, I don’t know how the Chaikin Analytics Power Gauge (a proprietary technical investing tool) calculated the P/E, which is why I asked. I think of you as being a savvy yet grumpy investor (or very much like one) and so I’m surprised you would question whether a high P/E ratio is good or not. A very high P/E is unquestionably good for buy-and-hold “long” investors (but could be Hell on shorts), but in this case, hard to fathom because it’s obviously not based on conventional methods of determining P/E. I'll make it simple, any auto-generated stock evaluator will simply do "high P/E bad, low P/E good". As for being good for long term buy and hold, companies able to withstand a very high P/E ratio over an extended period are extremely rare (Nvidia, Tesla, Amazon, etc.). Calling it "unquestionably good" is completely wrong. |
|
